Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Feb;78(2):257–259. doi: 10.1111/j.1476-5381.1983.tb09388.x

The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart.

N J Birdsall, A S Burgen, E C Hulme, J M Stockton, M J Zigmond
PMCID: PMC2044719  PMID: 6187403

Abstract

McN-A-343 behaves as a competitive agonist in binding to muscarinic receptors in the cerebral cortex. In its interaction with myocardial muscarinic receptors it is not competitive but it retains features of agonist binding.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun. 1979 Apr 27;87(4):1000–1005. doi: 10.1016/s0006-291x(79)80006-6. [DOI] [PubMed] [Google Scholar]
  2. Birdsall N. J., Burgen A. S., Hulme E. C. The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 1978 Sep;14(5):723–736. [PubMed] [Google Scholar]
  3. Birdsall N. J., Hulme E. C., Burgen A. The character of the muscarinic receptors in different regions of the rat brain. Proc R Soc Lond B Biol Sci. 1980 Feb 13;207(1166):1–12. doi: 10.1098/rspb.1980.0011. [DOI] [PubMed] [Google Scholar]
  4. Fozard J. R., Muscholl E. Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br J Pharmacol. 1972 Aug;45(4):616–629. doi: 10.1111/j.1476-5381.1972.tb08119.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  6. Hulme E. C., Birdsall N. J., Burgen A. S., Mehta P. The binding of antagonists to brain muscarinic receptors. Mol Pharmacol. 1978 Sep;14(5):737–750. [PubMed] [Google Scholar]
  7. ROSZKOWSKI A. P. An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther. 1961 May;132:156–170. [PubMed] [Google Scholar]
  8. Rosenberger L. B., Roeske W. R., Yamamura H. I. The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue. Eur J Pharmacol. 1979 Jun;56(1-2):179–180. doi: 10.1016/0014-2999(79)90451-5. [DOI] [PubMed] [Google Scholar]
  9. Wei J. W., Sulakhe P. V. Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides. Eur J Pharmacol. 1979 Sep 1;58(1):91–92. doi: 10.1016/0014-2999(79)90346-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES